Glenmark Pharmaceuticals Europe Ltd.

Carbocisteine - Glenmark Pharmaceuticals Europe Ltd

Mucolytic to facilitate expectoration.

• Child 2–4 years: 62.5–125 mg, 4 times daily
• Child 5–11 years: 250 mg, 3 times daily
• Over 12 years: initially 2.25 g daily in divided doses, then 1.5 g daily in divided doses as condition improves

Dexamethasone - Glenmark Pharmaceuticals Europe Ltd

Suppression of inflammatory and allergic disorders by mouth
• Child: 10–100 mcg/kg daily in 1–2 divided doses.
• Adult: 0.5–10 mg daily.

Mild croup by mouth
Child: 150 mcg/kg for 1 dose

Severe croup by mouth
Child: initially 150 mcg/kg before transfer t…

Fluticasone propionate and salmeterol - Glenmark Pharmaceuticals Europe Ltd

Long-acting selective beta2 agonist with corticosteroid.

Stalpex 500/50 mcg
• For symptomatic treatment of COPD with a FEV1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite re…

Ryaltris - Mometasone furoate with olopatadine hydrochloride

For treatment of moderate to severe nasal symptoms associated with allergic rhinitis in adults and adolescents of 12 years of age and older.

• Adults and adolescents of 12 years of age and older: two actuations into each nostril, twice daily

Soprobec - beclometasone (beclomethasone) dipropionate

Soprobec is indicated for the maintenance treatment of asthma, when the use of pressurised metered dose inhaler is appropriate.

• Child: 100 mcg twice daily, increased if necessary up to 400 mcg daily in 2–4 divided doses.
• Adult: 200 mcg twice daily, …

Stalpex - salmeterol and fluticasone propionate

For severe asthma in patients 12 years of age and older only where use of a combination product (long-acting beta2 agonist and inhaled corticosteroid) is appropriate: patients not adequately controlled on a lower strength corticosteroid combination p…

Tiogiva - Tiotropium